Clinical Trials Arena on MSN
EnteroBiotix nets $25m to progress microbiome-based IBS drug
The biotech’s CEO, Dr James McIlroy, says EBX-102-02 could address significant treatment gaps in IBS, which impacts up to 10% ...
Too often, people promote remedies for irritable bowel syndrome that have little to no scientific backing.
The FDA has approved Linzess capsules for treating irritable bowel syndrome with constipation in pediatric patients seven years and older, according to a Nov. 5 news release. Here are five things to ...
Separate poster will feature long-term safety and tolerability data from STARS clinical trial program of apraglutide in adults with SBS who are dependent on parenteral support (PS) –– Linaclotide data ...
A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...
Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results